# Avidia Bancorp, Inc.: financial statements, quarterly

AVBC · NYSE · CIK 2058758 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/avbc.md) · [Financials](/companies/avbc/financials.md) · [Filings](/companies/avbc/filings.md) · [Insiders](/companies/avbc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/avbc/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Income tax | $m | [1.2](/filings/0000950170-25-090660.md) | [0.8](/filings/0000950170-25-108987.md) | [0.7](/filings/0001193125-25-283184.md) | [1.3 d](/filings/0001193125-26-129221.md) | [(4.9)](/filings/0001193125-26-224283.md) | [1.2](/filings/0001193125-26-349298.md) | [(1.0)](/filings/0001193125-25-283184.md) | [2.4 d](/filings/0001193125-26-129221.md) | [2.2](/filings/0001193125-26-224283.md) | [2.3](/filings/0001193125-26-349298.md) |
| Net income | $m | [3.5](/filings/0000950170-25-090660.md) | [2.4](/filings/0000950170-25-108987.md) | [2.1](/filings/0001193125-25-283184.md) | [3.5 d](/filings/0001193125-26-129221.md) | [(11.6)](/filings/0001193125-26-224283.md) | [3.9](/filings/0001193125-26-349298.md) | [(0.9)](/filings/0001193125-25-283184.md) | [5.3 d](/filings/0001193125-26-129221.md) | [6.0](/filings/0001193125-26-224283.md) | [7.2](/filings/0001193125-26-349298.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | [(0.05)](/filings/0001193125-25-283184.md) | not reported | [0.32](/filings/0001193125-26-224283.md) | [0.39](/filings/0001193125-26-349298.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | [(0.05)](/filings/0001193125-25-283184.md) | not reported | [0.32](/filings/0001193125-26-224283.md) | [0.39](/filings/0001193125-26-349298.md) |

- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | not reported | not reported | not reported | not reported | [2,657](/filings/0001193125-26-129221.md) | [2,707](/filings/0000950170-25-090660.md) | [2,958](/filings/0000950170-25-108987.md) | [2,787](/filings/0001193125-25-283184.md) | [2,837](/filings/0001193125-26-349298.md) | [2,807](/filings/0001193125-26-224283.md) | [2,780](/filings/0001193125-26-349298.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [2,463](/filings/0001193125-26-129221.md) | [2,521](/filings/0000950170-25-090660.md) | [2,766](/filings/0000950170-25-108987.md) | [2,415](/filings/0001193125-25-283184.md) | [2,458](/filings/0001193125-26-349298.md) | [2,424](/filings/0001193125-26-224283.md) | [2,391](/filings/0001193125-26-349298.md) |
| Shareholders' equity | $m | [181](/filings/0001193125-26-129221.md) | [184](/filings/0000950170-25-108987.md) | [187](/filings/0001193125-25-283184.md) | [195](/filings/0001193125-25-283184.md) | [194](/filings/0001193125-26-349298.md) | [186](/filings/0001193125-26-349298.md) | [191](/filings/0001193125-26-349298.md) | [372](/filings/0001193125-25-283184.md) | [379](/filings/0001193125-26-349298.md) | [384](/filings/0001193125-26-349298.md) | [390](/filings/0001193125-26-349298.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.4](/filings/0000950170-25-090660.md) | [(0.6) d](/filings/0000950170-25-108987.md) | [2.5 d](/filings/0001193125-25-283184.md) | [19.9 d](/filings/0001193125-26-129221.md) | [(2.2)](/filings/0001193125-26-224283.md) | [(2.3) d](/filings/0001193125-26-349298.md) | [24.1 d](/filings/0001193125-25-283184.md) | [8.8 d](/filings/0001193125-26-129221.md) | [8.4](/filings/0001193125-26-224283.md) | [10.1 d](/filings/0001193125-26-349298.md) |
| Capital expenditure | $m | [0.3](/filings/0000950170-25-090660.md) | [0.9 d](/filings/0000950170-25-108987.md) | [0.9 d](/filings/0001193125-25-283184.md) | [0.7 d](/filings/0001193125-26-129221.md) | [1.7](/filings/0001193125-26-224283.md) | [1.0 d](/filings/0001193125-26-349298.md) | [0.9 d](/filings/0001193125-25-283184.md) | [0.8 d](/filings/0001193125-26-129221.md) | [0.7](/filings/0001193125-26-224283.md) | [0.9 d](/filings/0001193125-26-349298.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [1.0](/filings/0001193125-26-224283.md) | [1.0 d](/filings/0001193125-26-349298.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [18.5](/filings/0001193125-25-283184.md) | [18.6](/filings/0001193125-26-224283.md) | [18.6](/filings/0001193125-26-349298.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 19,970,306 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001193125-26-349298.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.